[Pharmacological modification of the human myometrium activity in in-vitro experiments. 7. Final considerations. Effect of Spasman on the isolated uterine muscle strip].
D000328:Adult; D004338:Drug Combinations; D004347:Drug Interactions; D004809:Ephedrine / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D011247:Pregnancy; D014282:Trihexyphenidyl / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects* / Q000502:physiology
D004338:Drug Combinations; D010276:Parasympatholytics; D010627:Phenethylamines; D014282:Trihexyphenidyl; D004809:Ephedrine
Pharmakologische Beeinflussung der Aktivität des menschlichen Myometriums im in in-vitro-Versuch. 7. Mitteilung und Schlubbbetrachtung. Spasmanwirkung auf das isolierte Uterusmuskelstreifenpräparat.